Link To ::
Largent A, Grady C. Miller FG, Wertheimer A. Money, Coercion, and Undue Inducement: Attitudes about Payments to Research Participants. IRB: Ethics & Human Research 2012 January-February. Accessed on 2012-02-29 at: http://www.thehastingscenter.org/Publications/IRB/Detail.aspx?id=5705
Lee K, Bacchetti P, Sim I. Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis. PLoS Med 2008;5(9) e191. Accessed on 2008-09-24 at: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050191
Lemmens T, Thompson A. Noninstitutional commercial review boards in North America: A critical appraisal and comparision with IRBs. IRB: Ethics & Human Research 2001; 23(2): 1-12. Accessed on 2006-08-22 at: http://www.law.utoronto.ca/documents/Lemmens/noninstitutionalboards.pdf
Lemmens T, Miller PB. Avoiding a Jekyll and Hyde Approach to the Ethics of Clinical Research and Practice. American Journal of Bioethics 2002;2(2):14-17. Accessed on 2006-08-22 at: http://www.law.utoronto.ca/documents/Lemmens/JekyllandHyde.pdf
Lemmens T, Miller PB. Regulating the market in human research participants. PLoS Med 2006;3(8):e330. Accessed on 2006-08-22 at: http://medicine.plosjournals.org/archive/1549-1676/3/8/pdf/10.1371_journal.pmed.0030330-L.pdf
Lerner BH. Sins of Omission in Cancer Research without Informed Consent. N Engl J Med 2004;351:628-630. Accessed on 2006-07-28 at: http://content.nejm.org/cgi/content/full/351/7/628 (Requires free registration.)
Levine RH. A Researcher's Concern with Ethics in Human Research. The Journal of the California Alliance for the Mentally Ill. 5(1). Accessed on 2006-03-02 at: http://www.healthieryou.com/j51.html
Lovell MC. Second Thoughts: Do the FDA's Responses to a Fatal Drug Trial and the AIDS Activist Community's Doubts About Early Access to Drugs Hint at a Shift in Basic FDA Policy? Food & Drug L. J. 1996; 51: 273-294. Accessed on 2006-05-01 at: http://www.fdli.org/pubs/Journal%20Online/51_2/art6.pdf
Lynn J, Baily MA, Bottrell M, Jennings B, Levine RJ, Davidoff F, Casarett D, Corrigan J, Fox E, Wynia MK, Agich GJ, O'Kane M, Speroff T, Schyve P, Batalden P, Tunis S, Berlinger N, Cronenwett L, Fitzmaurice JM, Dubler NN, James B. The ethics of using quality improvement methods in health care. Ann Intern Med 2007;146(9):666-673 Epub 2007 Apr 16. Accessed on 2007-05-03 at: http://www.annals.org/cgi/content/full/146/9/666
Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA. Lessons on Ethical Decision Making from the Bioscience Industry. PLoS Med 2006; 3(5): e129. Accessed on 2006-05-09 at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1434482
Magnus D, Cho MK. Issues in Oocyte Donation for Stem Cell Research. Science 2005; 308(5729): 1747-1748. Accessed on 2006-05-09 at: http://www.sciencemag.org/cgi/content/full/308/5729/1747
Mann H, Djulbegovic B. Choosing a control intervention for a randomised clinical trial. BMC Medical Research Methodology 2003;3:7. Accessed on 2006-03-02 at: http://www.biomedcentral.com/content/pdf/1471-2288-3-7.pdf
Mascalzoni D, Hicks A, Pramstaller P, Wjst M (2008) Informed Consent in the Genomics Era. PLoS Med 5(9): e192. Accessed on 2008-10-18 at: http://dx.doi.org/10.1371/journal.pmed.0050192
Matsui D, Kwan C, Steer E, Rieder MJ. The trials and tribulations of doing drug research in children. CMAJ 2003;169 (10):1033-1034. Accessed on 2006-03-02 at: http://www.cmaj.ca/cgi/content/full/169/10/1033
Mayer M. When Clinical Trials Are Compromised: A Perspective from a Patient Advocate. PLoSMed 2005;2(11):e358. Accessed on 2006-04-27 at: http://medicine.plosjournals.org/archive/1549-1676/2/11/pdf/10.1371_journal.pmed.0020358-S.pdf
McManus J, Mehta SG, McClinton AR, De Lorenzo RA, Baskin TW. Informed Consent and Ethical Issues in Military Medical Research. Acad Emerg Med 2005;12(11):1120-1126. Accessed on 2006-05-14 at: http://www.aemj.org/cgi/content/full/12/11/1120
McCray AT, Dorfman E, Ripple A, Ide NC, Jha M, Katz DG, Loane RF, Tse T. Usability issues in developing a Web-based consumer health site. Proc AMIA Symp. 2000;:556-60. Accessed on 2006-09-19 at: http://www.amia.org/pubs/symposia/D200684.PDF
McCray AT, Ide NC. Design and Implementation of a National Clinical Trials Registry. J Am Med Inform Assoc. 2000 May-Jun;7(3):313-323. Accessed on 2006-09-19 at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=10833169
Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA. Perceptions of Patients and Physicians Regarding Phase I Cancer Clinical Trials: Implications for Physician-Patient Communication. J Clin Oncol. 2003;21(13):2589-2596. Accessed on 2006-03-02 at: http://www.jco.org/cgi/reprint/21/13/2589
Miller FG, Grady C. The Ethical Challenge of Infection–Inducing Challenge Experiments. Clinical Infectious Diseases. 2001;33(7):1028–1033. Accessed on 2008-03-04 at: http://www.journals.uchicago.edu/doi/full/10.1086/322664
Miller FG, Wendler D, Swartzman LC. Deception in Research on the Placebo Effect. PLoS Med 2005; 2(9): e262. Accessed on 2009-03-13 at: http://dx.doi.org/10.1371/journal.pmed.0020262
Minchew BH, Gallogly C. Informed Consent. FDA Papers October 1967: 8-11. http://www.circare.org/fda/informedconsent_fdapapers_101967.pdf
Morin K, Rakatansky H, Riddick FA, Morse LJ, O'Bannon JM, Goldrich MS, Ray P, Weiss M, Sade RM, MD; Monique A. Spillman MA. Managing Conflicts of Interest in the Conduct of Clinical Trials. JAMA 2002;287:78-84. Accessed on 2006-03-02 at: http://jama.ama-assn.org/cgi/reprint/287/1/78.pdf
Morreim EH. Medical research litigation and malpractice tort doctrines: Courts on a learning curve. 4 Hous. J. Health L & Pol'y. 2003. Accessed on 2008-03-26 at: http://www.ohsu.edu/research/rda/education/irbconference/presentation/litigation.pdf
Morreim EH. By Any Other Name: The Many Iterations of Patient Advocate
in Clinical Research. IRB 2004;26(6):1-8. (Reprinted by Medscape.) Accessed on 2008-03-26 at: http://www.medscape.com/viewarticle/496529_print
Morris MC, Nadkarni VM, Ward FR, Nelson RM. Exception From Informed Consent for Pediatric Resuscitation Research: Community Consultation for a Trial of Brain Cooling After In-Hospital Cardiac Arrest. Pediatrics 2004;114(3):776-781. Accessed on 2006-03-25 at: http://dx.doi.org/10.1542/peds.2004-0482
Moses H, Dorsey ER, Matheson DH, Thier SO. Financial Anatomy of Biomedical Research. JAMA 2005;294:1333-1342. Accessed on 2007-01-10 at: http://jama.ama-assn.org/cgi/reprint/294/11/1333
Mortimer B, Olsen DB. Ten Years After Barney Clark: Registry and Tabulations of Clinical Progress with the Artificial Heart Since 1982. University of Utah Journal of Undergraduate Research 1992;3(1):18-27. Accessed on 2006-09-30 at: http://www.lib.utah.edu/epubs/undergrad/vol3/mortimer.pdf
Moyer CA. Between-Groups Study Designs Demand Between-Groups Analyses: A Response to Hernandez-Reif, Shor-Posner, Baez, Soto, Mendoza, Castillo, Quintero, Perez, and Zhang. eCAM 2009;6910:49-50. Accessed on 2009-03-09 at: http://ecam.oxfordjournals.org/cgi/content/full/6/1/49
Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death. JAMA 2008;299(19):2304-2312. Accessed on 2008-09-30 at: http://jama.ama-assn.org/cgi/content/full/299.19.jrv80007
Nebeker JR, Barach P, Samore MH. Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting. Ann Intern Med. 2004;140:795-801. Accessed on 2006-03-02 at: http://www.annals.org/cgi/reprint/140/10/795.pdf
Okie S. Access before Approval — A Right to Take Experimental Drugs? N Engl J Med. 2006; 355(5): 437-440. Accessed on 2006-08-24 at: http://content.nejm.org/cgi/content/full/355/5/437
Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M. Accuracy of Conflict-of-Interest Disclosures Reported by Physicians. N Engl J Med 2009;361:1466-74. Accessed on 2009-10-12 at: http://content.nejm.org/cgi/reprint/361/15/1466.pdf
Ornato JP, for the PAD Trial Investigators. The Public Access Defibrillation (PAD) Trial study design and rationale. Resuscitation. 2003; 56: 135-147. Accessed on 2006-03-21 at: http://www.fda.gov/ohrms/dockets/dockets/95s0158/95s-0158-rpt0011-02.pdf
Park RL. The Seven Warning Signs of Bogus Science. The Chronicle of Higher Education. 2003-01-31. Accessed on 2006-03-02 at: http://chronicle.com/free/v49/i21/21b02001.htm
Pentz RD. Spreading it Around: Money for Researchers and Research Participants. The Mount Sinai Journal of Medicine. 2004;71(4):266-270. Accessed on 2006-05-04 at: http://www.mssm.edu/msjournal/71/71_4_pages_266_270.pdf
The PLoS Medicine Editors. How Can We Draw the Line between Clinical Care and Medical Research. PLoS Med. 2007; 4(11): e340. Accessed on 2009-03-13 at: http://dx.doi.org/10.1371/journal.pmed.0040340
The PLoS Medicine Editors. An Unbiased Scientific Record Should Be Everyone's Agenda. PLoS Med 2009; 6(2): e1000038. Accessed on 2009-03-13 at: http://dx.doi.org/10.1371/journal.pmed.1000038
Raftery J, Bryant J, Powell J, Kerr C, Hawker S. Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. Health Technol Assess. 2008;12(10):1-128. Accessed on 2009-04-04 at: http://www.hta.ac.uk/fullmono/mon1210.pdf
Raju TNK. Hot Brains: Manipulating Body Heat to Save the Brain. Pediatrics. 2006;117(2):e320-321. Accessed on 2006-09-08 at: http://pediatrics.aappublications.org/cgi/reprint/117/2/e320
Reiser SJ. Research compensation and the monetarization of medicine. JAMA. 2005;293(5):613-4. Accessed on 2006-03-10 at: http://jama.ama-assn.org/cgi/content/full/293/5/613 (Free registration required.)
Resnick DB. Eliminating the daily life risks standard from the definition of minimal risk. J Med. Ethics. 2005;31:35-38. Accessed on 2006-05-10 at: http://jme.bmjjournals.com/cgi/content/full/31/1/35
Rettig RA. The Industrialization of Clinical Research. Health Affairs 2000;19(2):129-146. Accessed on 2008-03-26 at: http://content.healthaffairs.org/cgi/reprint/19/2/129.pdf
Rhodes R, Strain JJ. Whistleblowing in academic medicine. J Med Ethics. 2004;30:35-39. Accessed on 2006-01-14 at: http://jme.bmjjournals.com/cgi/content/full/30/1/35
Roberts LW, Hammond KA, Warner TD, Lewis R. Influence of Ethical Safeguards on Research Participation: Comparison of Perspectives of People With Schizophrenia and Psychiatrists. Am J Psychiatry. 2004;161:2309-2311. Accessed on 2006-03-02 at: http://ajp.psychiatryonline.org/cgi/reprint/161/12/2309
Roberts TG, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW. Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials. JAMA. 2004;292:2130-2140. Accessed on 2006-03-02 at: http://jama.ama-assn.org/cgi/content/abstract/292/17/2130 (Free registration required.)
Robinson EJ, Kerr CEP, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG. Lay public's understanding of equipoise and randomisation in randomised controlled trials. Health Technol Assess. 2005;9(8). Accessed on 2006-04-27 at: http://www.hta.ac.uk/fullmono/mon908.pdf
Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM, 2009 Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis. PLoS Med 6(9): e1000144. Accessed on 2010-09-08 at: http://dx.doi.org/10.1371/journal.pmed.1000144
Sammons HM, Gray C, Hudson H, Cherrill J, Choonara I. Safety in paediatric clinical trials - a 7-year review Acta Paediatrica 2008;97(4):474–477. Accessed on 2008-03-21 at: http://dx.doi.org/10.1111/j.1651-2227.2008.00676.x
Savulescu J. Harm, ethics committees and the gene therapy death. J Med. Ethics. 2001;27:148-150. Accessed on 2006-05-10 at: http://jme.bmjjournals.com/cgi/content/full/27/3/148
Savulescu J, Spriggs M. The hexamethonium asthma study and the death of a normal volunteer in research. J Med. Ethics. 2002;28:3-4. Accessed on 2006-05-10 at: http://jme.bmjjournals.com/cgi/content/full/28/1/3
Sayers GM. Should Research Ethics Committees be told how to think? J Med. Ethics. 2006. ** Pre-Publication. Accessed on 2006-05-10 at: http://jme.bmjjournals.com/preprint/sayers.pdf
Sampson W. The Alternative Universe. TCS: Tech Central Station. 2002-12-09. Accessed on 2006-03-02 at: http://www.techcentralstation.com/120902C.html
Sansone RA, McDonald S, Hanley P, Sellbom M, Gaither GA. The stipulations of one institutional review board: a five year review. J Med Ethics. 2004;30:308-310. Accessed on 2006-03-02 at: http://jme.bmjjournals.com/cgi/reprint/30/3/308
Schaefer OG, Emmanuel EJ, Wertheimer, A. The Obligation to Participate in Biomedical Research. JAMA 2009;302(1): 67-72: http://dx.crossref.org/10.1001%2Fjama.2009.931
Schwartz JD. Oversight of Human Subject Research: The Role of the States. in: Ethical and Policy Issues in Research Involving Human Participants Volume II Commissioned Papers and Staff Analysis. National Bioethics Advisory Commission, Bethesda, Maryland (August 2001) ISBN 1-931022-17-8. Accessed on 2006-03-02 at: http://www.georgetown.edu/research/nrcbl/nbac/human/overvol2.html
Schwartz RS. The Politics and Promise of Stem-Cell Research. N Engl J Med 2006;355(12):1189-1191. Accessed on 2006-09-20 at: http://content.nejm.org/cgi/content/full/355/12/1189
Schwitzer G, Mudur G, Henry D, Wilson A, Goozner M, Simbra M, Sweet M, Baverstock KA. What Are the Roles and Responsibilities of the Media in Disseminating Health Information? PLoS Med. 2005;2(7):e215. Accessed on 2006-03-02 at: http://medicine.plosjournals.org/archive/1549-1676/2/7/pdf/10.1371_journal.pmed.0020215-S.pdf
Sehon SR, Stanley DE. A philosophical analysis of the evidence-based medicine debate. BMC Health Services Research. 2003;3:14. Accessed on 2006-03-02 at: http://www.biomedcentral.com/content/pdf/1472-6963-3-14.pdf
Sekeres M, Gold JL, Chan AW, Lexchin J, Moher D, Van Laethem ML, Maskalyk J, Ferris L, Taback N, Rochon PA. Poor reporting of scientific leadership information in clinical trial registers. PLoS ONE. 2008;3(2):e1610. Accessed on 2008-02-26 at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2229844&blobtype=pdf
Shah S, Whittle A, Wilfond B, Gensler G, Wendler D. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA 2004;291:476-82. Accessed on 2006-04-30 at: http://jama.ama-assn.org/cgi/content/full/291/4/476 (Free registration required.)
Shalowitz DI, Miller FG. Communicating the Results of Clinical Research to Participants: Attitudes, Practices, and Future Directions. PLoS Med 2009;5(5):e91. Accessed on 2009-04-04 at: http://dx.doi.org/10.1371/journal.pmed.0050091
Shamoo, AE. The Myth of Equipoise in Phase 1 Clinical Trials. Medscape J Med. 2008;10(11):254. Accessed on 2009-02-03 at: http://www.medscape.com/viewarticle/582554 (Requires free registration)
Silversides A. Clinical trials: the muddled Canadian landscape. CMAJ 2009;180(1). Accessed on 2009-03-17 at: http://dx.doi.org/10.1503/cmaj.081897
Silversides A. Clinical trial participation poses ethical, practical issues. CMAJ 2009;180(5). Accessed on 2009-03-17 at: http://dx.doi.org/10.1503/cmaj.090131
Sim I, Detmer DE. Beyond Trial Registration: A Global Trial Bank for Clinical Trial Reporting. PLoSMed 2005;2(11):e365. Accessed on 2006-04-27 at: http://medicine.plosjournals.org/archive/1549-1676/2/11/pdf/10.1371_journal.pmed.0020365-S.pdf
Singh JA, Abdool Karim SS, Abdool Karim Q, Mlisana K, Williamson C, Gray C, Govender M, Gray A. Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South Africa. PLoS Med 3(7):e180. Accessed on 2006-06-09 at: http://medicine.plosjournals.org/archive/1549-1676/3/7/pdf/10.1371_journal.pmed.0030180-p-S.pdf
Sinnott-Armstrong, Walter Consequentialism
, The Stanford Encyclopedia of Philosophy (Spring 2006 Edition), Edward N. Zalta (ed.), forthcoming URL = http://plato.stanford.edu/archives/sum2003/entries/consequentialism/. Accessibility verified 2006-03-10.
Sipp D. Regen Med (2011) 6(3), 407-414. Accessed on 2012-02-29 at: http://www.futuremedicine.com/doi/pdfplus/10.2217/rme.11.13
Slyter H. Ethical Challenges in Stroke Research. Stroke. 1998;29:1725-1729. Accessed on 2006-11-09 at: http://stroke.ahajournals.org/cgi/content/full/29/8/1725
Sokal A. Transgressing the Boundaries: Toward a Transformative Hermaneutics of Quantum Gravity. Social Text. Spring/Summer 1996;46/47:217-252. Accessed on 2006-03-10 at: http://www.physics.nyu.edu/faculty/sokal/transgress_v2/transgress_v2_singlefile.html
Sox HC, Rennie D. Research Misconduct, Retraction, and Cleansing the Medical Literature: Lessons from the Poehlman Case. Ann Intern Med 2006;144(8):609-613. Accessed on 2006-04-25 at: http://www.annals.org/cgi/content/full/144/8/609
Stafford G. Case Study: Patient Privacy, Marketing Conflict. Oregon Board of Medical Examiners BME Report. Winter 2003:11. Accessed on 2006-03-02 at: http://egov.oregon.gov/BME/newsletter/Winter2003.pdf
Stang A, Hense H–W, Jöckel K–H, Turner EH, Tramèr. Is It Always Unethical to Use a Placebo in a Clinical Trial. PLoS Med. 2005;2(3): e72. Accessed on 2007-10-27 at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?&pubmedid=15783259
Steinbrook R. Registration of Clinical Trials — Voluntary or Mandatory? N Engl J Med 2004;351(18):1820-2. Accessed on 2006-03-02 at: http://content.nejm.org/cgi/content/full/351/18/1820 (Free registration required.)
Stolley PD. The Hazards of Misguided Compassion. Ann Intern Med. 1993;118(10):822-823. Accessed on 2008-03-05 at: http://0-www.annals.org.pugwash.lib.warwick.ac.uk/cgi/content/full/118/10/822
Shuchman M. Clinical trials: the balance between protecting participants and promoting drug and product development. CMAJ 2009; 180(6) Accessed on 2009-03-17 at: http://dx.doi.org/10.1503/cmaj.090217
Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N. Brief Report: Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412. N Engl J Med 2006; 355:1018-1028, Sep 7, 2006; published at www.nejm.org on Aug 14, 2006. Accessed on 2006-09-19 at: http://content.nejm.org/cgi/content/full/355/10/1018
Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments: part 1: ethical and scientific issues. Ann Intern Med 2000;133:455-463. Accessed on 2006-04-30 at: http://www.annals.org/cgi/content/full/133/6/455
Tereskerz PM, Guterbock TM, Kermer DA, Moreno JD (2011): An Opinion and Practice Survey on the Structure and Management of Data and Safety Monitoring Boards, Accountability in Research: Policies and Quality Assurance, 18:1, 1-30: http://dx.doi.org/10.1080/08989621.2011.542680
Tisherman SA, Powell JL, Schmidt TA, Aufderheide TP, Kudenchuk PJ, Spence J, Climer D, Kelly D, Marcantonio A, Brown T, Sopko G, Kerber R, Sugarman J, Hoyt D; Resuscitation Outcomes Consortium Investigators. Regulatory challenges for the resuscitation outcomes consortium. Circulation. 2008;118(15):1585-92. Accessed on 2008-10-31 at: http://circ.ahajournals.org/cgi/content/full/118/15/1585
Toigo T. Food and Drug Modernization Act (FDAMA) Section 113: Status Report on Implementation. J. Biolaw & Business 2004;7(2). Accessed on 2007-01-10 at: http://www.fda.gov/oashi/clinicaltrials/section113/biolaw.html
U.S. Food and Drug Administration. FDAMA Section 113: Status Report on Implementation. August, 2005. Accessed on 2007-01-10 at: http://www.fda.gov/oashi/clinicaltrials/section113/113report/default.htm
U.S. Food and Drug Administration. FDAMA Section 113: 2005 Status Report on Implementation. June, 2006. Accessed on 2007-01-10 at: http://www.fda.gov/oashi/clinicaltrials/section113/2005statusreport/
Drazin J, Zarin DA. Salvation by Registration. N Engl J Med 2007;356(2):184-185. Accessed on 2007-01-10 at: http://content.nejm.org/cgi/content/full/356/2/184
Indexed information: U.S. Food and Drug Administration. Food and Drug Administration Modernization Act (FDAMA) Section 113 and ClinicalTrials.gov. Accessed on 2007-01-10 at: http://www.fda.gov/oashi/clinicaltrials/section113/default.htm
Turner EH. A Taxpayer-Funded Clinical Trials Registry and Results Database. PLoS Med. 2004;1(3):e60. Accessed on 2006-03-02 at: http://medicine.plosjournals.org/archive/1549-1676/1/3/pdf/10.1371_journal.pmed.0010060-p-L.pdf
Turner EH, Matthews AM, Lindardatos E, Tell RA, Rosenthal R. Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. N Engl J Med 2008;358:252-260. Accessed on 2008-03-20 at: http://content.nejm.org/cgi/reprint/358/3/252.pdf
Turner EH, Rosenthal R. Efficacy of antidepressants. BMJ 2008;336:532-534. Accessed on 2008-03-20 at: http://www.bmj.com/cgi/content/full/336/7643/516
Turner EH, Knoepflmacher D, Shapley L. (2012) Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the US Food and Drug Administration Database. PLoS Med 9(3): e1001189: http://dx.doi.org/10.1371/journal.pmed.1001189
Vickers AJ. Do we want more cancer patients on clinical trials. Trials 2008;9:31. Accessed on 2010-03-14 at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429895/pdf/1745-6215-9-31.pdf
Wainwright P, Saunders J. What are local issues? The problem of the local review of research. J Med Ethics. 2004;30: 313-317. Accessed on 2006-03-02 at: http://jme.bmjjournals.com/cgi/reprint/30/3/313
Wax PM. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act.Ann Intern Med. 1995;122(6):456-61. Accessed on 2008-02-28 at: http://www.annals.org/cgi/content/full/122/6/456
Wendler D, Belsky L, Thompson KM, Emanuel EJ. Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA. 2005;294(7):826-32. Accessed on 2006-03-02 at: http://jama.ama-assn.org/cgi/content/full/294/7/826 (Free registration required.)
Whitney SN, Alcser K, Schneider CE, McCullough LB, McGuire AL, Volk RJ. Principal Investigators Views of the IRB System. Int J Med Sci. 2008;5:68-72. Accessed on 2009-02-03 at: http://www.medsci.org/v05p0068.pdf
Willison DJ, Kapral MK, Peladeau P, Richards JA, Fang J, Silver FL. Variation in recruitment across sites in a consent-based clinical data registry: lessons from the Canadian Stroke Network. BMC Medical Ethics. 2006;7:6. Accessed on 2006-05-24 at: http://www.biomedcentral.com/content/pdf/1472-6939-7-6.pdf
Wolf S et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genetics In Medicine (2012): http://dx.doi.org/10.1038/gim.2012.23
Wood A, Grady C, Emanuel EJ. Regional ethics organizations for protection of human research participants. Nature Medicine. 2004;10(1283):1288. Accessed on 2006-03-02 at: http://www.nature.com/cgi-taf/DynaPage.taf?file=/nm/journal/v10/n12/full/nm1204-1283.html
Yuval R, Halon DA, Merdler A, Khader N, Karkabi B, Uziel K, Lewis BS. Patient Comprehension and Reaction to Participating in a Double-blind Randomized Clinical Trial (ISIS-4) in Acute Myocardial Infarction. Arch Intern Med. 2000;160:1142-1146. Accessed on 2006-03-10 at: http://archinte.ama-assn.org/cgi/content/full/160/8/1142 (Free registration required.)
Yuval R, Halon DA, Lewis BS. Patients' Point of View in Heart Failure Trials. JAMA. 2001;285:883-884. Accessed on 2006-03-10 at: http://jama.ama-assn.org/cgi/content/full/285/7/883-b (Free registration required.)
Zlotnik Shaul R, Birenbaum S, Evans M. Legal liabilities in research: early lessons from North America. BMC Med Ethics 2005;6:E4. Accessed on 2006-05-09 at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1182131
Zimmerman RK, Wolfe RM, Fox DE, Fox JR, Nowalk MP, Troy JA, Sharp LK. Vaccine criticism on the World Wide Web. : J Med Internet Res. 2005;7(2):e17. Accessed on 2006-10-14 at: http://www.jmir.org/2005/2/e17/
Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of antivaccination web sites. JAMA 2002;287(24):3245-3248. Accessed on 2006-10-14 at: http://jama.ama-assn.org/cgi/content/full/287/24/3245 (Free registration required.)
Davies P, Chapman S, Leask J. Antivaccination activists on the world wide web. Arch Dis Child. 2002;87(1):22-25. Accessed on 2006-10-14 at: http://adc.bmjjournals.com/cgi/content/full/87/1/22
Guyer RL, Moreno JD. Slouching Toward Policy: Lazy Bioethics and the Perils of Science Fiction. AJOB. 2004;4(4):W14. Available from http://taylorandfrancis.metapress.com/media/07WPXGLHXH3MME2JQJFT/Contributions/P/0/N/G/P0NGXAN5V96FY4RB.pdf
Illes J, Kann D, Karetsky K, et al. Advertising, patient decision making, and self-referral for computed tomographic and magnetic resonance imaging. Arch Intern Med. 2004;164:2415-2419. Available from http://archinte.ama-assn.org/cgi/content/full/164/22/2415
Lasser K, Seger DL, Yu T, Karson DS, Fiskio JM, Seger AC, Shah NR, Gandhi TK, Rothschild JM, Bates DW. Adherence to Black Box Warnings for Prescription Medications in Outpatients. Arch Intern Med. 2006;166:338-344. Available from http://archinte.ama-assn.org/cgi/content/short/166/3/338
Lockwood AH. Health Policy and Ethics Human Testing of Pesticides: Ethical and Scientific Considerations. American Journal of Public Health. 2004;94(11):1908-1916. Available from http://www.ajph.org/cgi/content/abstract/94/11/1908
Moreno JD. IRBs Under the Microscope. Kennedy Institute of Ethics Journal. 1998;8(3):329-337. Available from http://muse.jhu.edu/journals/kennedy_institute_of_ethics_journal/v008/8.3moreno.html
Sackett D. Participants in research. BMJ. 2005;330:1164. Available from http://bmj.bmjjournals.com/cgi/content/extract/330/7501/1164
Shamoo AE, Moreno JD. Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon. AJOB. 2004;(4)1:25-31. Available from http://www.bioethics.net/journal/j_articles.php?aid=38
These entries have yet to be revised. Your patience is appreciated.
(link dead) Margolis S. Alternative or Complementary Medicine in Middle Aged Men. Johns Hopkins White Papers. Available from http://www.hopkins-cam.org/whitepapers.html/white-papers.html
(link dead) MacDonald C. Out of the Frying Pan and into the Fire? The Alternativization of Women's Health. Annals RCPSC. 2002;35. Available from http://rcpsc.medical.org/english/annals/vol35-1e/outof_e.php3
(link dead) Roy N, Madhiwala N. Surving the Indian Pharmaceutical Jungle. Forum For Medical Ethics. 2003-11. Available from http://www.issuesinmedicalethics.org/docs/Pharmrpt.pdf
Drane JF. Honesty in Medicine: Should Doctors Tell the Truth? Accessed on 2006-03-10 at: http://www.uchile.cl/bioetica/doc/honesty.htm
Mizrachs S. Alternative medicine and appropriation of scientific discourse. Accessed on 2006-03-10 at: http://www.fiu.edu/~mizrachs/altern-med.html
Turpin R. Characterization of Quack Theories. Accessed on 2006-03-10 at: http://quasar.as.utexas.edu/BillInfo/Quack.html
Page last updated on: 2012-03-24
If you find the information on this page helpful please support CIRCARE with a tax deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Find out more on our Support page
All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education. Adobe® Reader :: ::
